| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/13/2000 | DE19831061A1 Reducing aggregate content of protein preparation, especially virus-inactivated therapeutic plasma protein or chemically modified protein preparation |
| 01/13/2000 | DE19830874A1 Verfahren zur Stabilisierung und Verbesserung des Gentransfers von genetischem Material in Säugerzellen A process for the stabilization and improvement of the gene transfer of genetic material into mammalian cells |
| 01/13/2000 | CA2402839A1 Galectin 11 |
| 01/13/2000 | CA2346742A1 Hyaluronic acid mimics and methods related thereto |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | CA2336718A1 Methods for treating neurological injuries and disorders |
| 01/13/2000 | CA2336709A1 Use of inhibitors of protein kinase c epsilon to treat pain |
| 01/13/2000 | CA2336656A1 Use of composition comprising at least one substance within the group gnrh-analogues for treatment of obsessive-compulsive disorder (ocd) |
| 01/13/2000 | CA2336406A1 Galectin 11 |
| 01/13/2000 | CA2336030A1 Bone cement with antimicrobial peptides |
| 01/13/2000 | CA2335918A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 01/13/2000 | CA2333919A1 Microsporidium polar tube proteins, nucleic acids coding for said proteins and their uses |
| 01/13/2000 | CA2333307A1 Compositions and methods for in vitro fertilization |
| 01/13/2000 | CA2332699A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | CA2332573A1 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | CA2332345A1 Flt3-l mutants and methods of use |
| 01/13/2000 | CA2332309A1 Neurotransmission associated proteins |
| 01/13/2000 | CA2332177A1 Proteases fused with variants of streptomyces subtilisin inhibitor |
| 01/13/2000 | CA2331829A1 Kv6.2, a voltage-gated potassium channel subunit |
| 01/13/2000 | CA2331771A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 01/13/2000 | CA2331394A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | CA2302169A1 Inhibitors of androgen-independent activation of androgen receptor |
| 01/12/2000 | EP0971033A2 Test and model for Alzheimer's disease |
| 01/12/2000 | EP0970965A1 Cyclic peptides and medicinal use thereof |
| 01/12/2000 | EP0970703A1 Stable, aqueous alfa interferon solution formulations |
| 01/12/2000 | EP0970700A2 Gallium containing medicaments for enhancing wound healing and tissue repair |
| 01/12/2000 | EP0970243A1 Diagnosis and treatment of glaucoma |
| 01/12/2000 | EP0970232A2 Non-immunogenic prodrugs and selectable markers for use in gene therapy |
| 01/12/2000 | EP0970227A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/12/2000 | EP0970223A1 Serine/threonine protein kinase |
| 01/12/2000 | EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 01/12/2000 | EP0970217A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use |
| 01/12/2000 | EP0970215A1 Suppressor of cytokine signaling |
| 01/12/2000 | EP0970214A1 Human muscle derived growth factor - cardiac and pancreatic protein (capp) and gene |
| 01/12/2000 | EP0970213A2 Death domain containing receptor 5 |
| 01/12/2000 | EP0970212A1 Secreted salivary zsig32 polypeptides |
| 01/12/2000 | EP0970211A1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 01/12/2000 | EP0970210A1 Methods of modulating p33ing1 mediated apoptosis |
| 01/12/2000 | EP0970209A1 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970208A1 Sp$g(a): A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO |
| 01/12/2000 | EP0970207A1 Heregulin variants |
| 01/12/2000 | EP0970206A1 Lage-1 tumor associated nucleic acids |
| 01/12/2000 | EP0970205A2 Human endosulfine gene |
| 01/12/2000 | EP0970204A1 Novel gene encoding male-transplantation antigen |
| 01/12/2000 | EP0970203A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 01/12/2000 | EP0970195A1 Fatty-acid amide hydrolase |
| 01/12/2000 | EP0970187A1 Pituitary differentiation factor and methods of use thereof |
| 01/12/2000 | EP0970186A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
| 01/12/2000 | EP0970128A1 Immunotherapeutic ctla-4 binding peptides |
| 01/12/2000 | EP0970127A1 Antibody variants |
| 01/12/2000 | EP0970126A2 Method for the production of antihuman antigen receptors and uses thereof |
| 01/12/2000 | EP0970124A2 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
| 01/12/2000 | EP0970123A2 GENOMIC SEQUENCE OF THE HUMAN $g(m)-OPIOID RECEPTOR GENE AND THE VARIANTS, POLYMORPHISMS AND MUTATIONS THEREOF |
| 01/12/2000 | EP0970122A1 Human anion channel |
| 01/12/2000 | EP0970121A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 01/12/2000 | EP0970120A2 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 01/12/2000 | EP0970118A1 Specific pancreatic lipase inhibitors and their applications |
| 01/12/2000 | EP0970116A1 Method of cell inhibition using polypeptides derived from the venom of the austrialian jumper ant myrmecia pilosula |
| 01/12/2000 | EP0970115A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 01/12/2000 | EP0970114A1 Neoglycoproteins |
| 01/12/2000 | EP0970113A1 Novel monomer elements for marking peptidic nucleic acids |
| 01/12/2000 | EP0970112A2 Novel human cytokine/steroid receptor protein |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970109A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970108A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970107A1 Cyclosporine derivatives and uses thereof |
| 01/12/2000 | EP0970106A1 uPAR MIMICKING PEPTIDE |
| 01/12/2000 | EP0970102A1 Antisense inhibition of angiogenin expression |
| 01/12/2000 | EP0969885A1 Process for stimulating neural regeneration |
| 01/12/2000 | EP0969877A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/12/2000 | EP0969875A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 01/12/2000 | EP0969873A1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 01/12/2000 | EP0969869A2 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
| 01/12/2000 | EP0969868A2 Methods and kits for treating and diagnosing leiomyomas |
| 01/12/2000 | EP0969866A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 01/12/2000 | EP0969865A1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 01/12/2000 | EP0969864A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 01/12/2000 | EP0969862A2 SYNTHETIC HIV $i(GAG) GENES |
| 01/12/2000 | EP0969861A1 Inhibiting hiv infection by cleaving co-receptor rna |
| 01/12/2000 | EP0969860A1 Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer |
| 01/12/2000 | EP0969859A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf) |
| 01/12/2000 | EP0969858A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 01/12/2000 | EP0969857A1 Pharmaceutical compositions |
| 01/12/2000 | EP0969856A1 Hydrophilic binary systems for the administration of cyclosporine |
| 01/12/2000 | EP0969855A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 01/12/2000 | EP0969853A1 Modulation of vascular healing by inhibition of leukocyte adhesion and function |
| 01/12/2000 | EP0969852A1 Combination therapy for the treatment of diabetes and obesity |
| 01/12/2000 | EP0969851A1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 01/12/2000 | EP0969840A1 Thrombin inhibitors |
| 01/12/2000 | EP0969823A2 Anti-epileptogenic agents |
| 01/12/2000 | EP0969816A1 Preparation of powder agglomerates |
| 01/12/2000 | EP0969814A1 Opthalmic non-irritating iodine medicament and method |
| 01/12/2000 | EP0969775A1 Bone marrow as a site for transplantation |
| 01/12/2000 | EP0969740A1 Improved process for the manufacture of collagen |
| 01/12/2000 | EP0969726A1 Treatment for dutch elm disease |
| 01/12/2000 | EP0969720A2 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 01/12/2000 | EP0778785B1 Methods and apparatus for the delivery of solid drug compositions |
| 01/12/2000 | EP0729362B1 TRANSDERMAL COMPOSITION OF N- N- 5- 4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-alpha-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
| 01/12/2000 | EP0639079B1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 01/12/2000 | EP0594764B1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |